Últimos artículos de Nutrition in Clinical Practice
- Fertility and pregnancy in patients with prolactinoma
- Pathophysiology and aetiologies of hypernatremia
- Hyponatremia and bone pathophysiology: An integrated preclinical and clinical perspective
- Proteomics and metabolomics biomarkers for predicting the onset and progression of diabetic complications: A systematic review and bioinformatics integration
- Sympathetic overactivity-induced type H endothelial cell senescence contributes to the impairment of vascularized osteogenesis by PKM2-mediated glycolysis in preclinical stages of Alzheimer's mice
- Diabetic neuropathy and fracture risk – a nation-wide case/control study
- Shape-based profiling of cortical bone mineral density in growing children: a proof-of-concept pQCT study
- Metabolic and osteogenic susceptibility in DISH: A prognostic index from propensity score modelling
- Bone mineral density and bone turnover changes with advanced menstrual recovery: The REFUEL study
- Reassessment of the Diagnostic Accuracy of HbA1c and Glucose for Type 2 Diabetes: A Systematic Review and Meta‐Analysis of Observational Studies
- Not All GLP‐1 Receptor Agonists Are Alike: Real‐World Evidence of Differential Endocrine and Dermatologic Safety
- Guidelines for replacement of a balloon gastrostomy tube in infants and pediatric patients: The American Society for Parenteral and Enteral Nutrition
- Issue Information
- Use of advanced technology for the treatment of type 1 diabetes in pregnancy
- The treatment of acute symptomatic hyponatraemia in the hospital setting
- Editorial Board
- A biological-systems-based analysis using proteomic and metabolic network inference reveals mechanistic insights into hepatic steatosis
- PFKFB3 nuclear translocation improves diabetic retinopathy by attenuating endothelial cell senescence through inhibition of USP7-p53 axis
- Enduring improvements in hepatic insulin sensitivity predict sustained remission of prediabetes during a 3-year lifestyle intervention: results from the PREVIEW multinational diabetes prevention trial
- The heart rate paradox and inferential limits of the GLP-1 receptor agonist–atrial fibrillation association